J P Farrell

1.1k total citations
24 papers, 968 citations indexed

About

J P Farrell is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Epidemiology. According to data from OpenAlex, J P Farrell has authored 24 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Public Health, Environmental and Occupational Health, 11 papers in Immunology and 6 papers in Epidemiology. Recurrent topics in J P Farrell's work include Research on Leishmaniasis Studies (21 papers), Trypanosoma species research and implications (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). J P Farrell is often cited by papers focused on Research on Leishmaniasis Studies (21 papers), Trypanosoma species research and implications (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). J P Farrell collaborates with scholars based in United States, Switzerland and China. J P Farrell's co-authors include Carl E. Kirkpatrick, Gary S. Nabors, Phillip Scott, Ingrid Müller, Philip Scott, Luís Afonso, Thierry Pedrazzini, Jacques Louis, J A Louis and David Abraham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Annual Review of Immunology.

In The Last Decade

J P Farrell

24 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J P Farrell United States 19 638 438 379 192 111 24 968
J A Louis Switzerland 16 991 1.6× 556 1.3× 549 1.4× 192 1.0× 216 1.9× 22 1.4k
P Natovitz United States 9 685 1.1× 434 1.0× 450 1.2× 274 1.4× 153 1.4× 9 1.1k
J G Howard United Kingdom 12 812 1.3× 484 1.1× 337 0.9× 212 1.1× 126 1.1× 18 1.1k
Reza Behin Switzerland 18 904 1.4× 623 1.4× 642 1.7× 298 1.6× 121 1.1× 23 1.4k
Charles Mary France 22 1.1k 1.7× 705 1.6× 295 0.8× 342 1.8× 233 2.1× 31 1.5k
R Pu United States 7 314 0.5× 467 1.1× 328 0.9× 88 0.5× 78 0.7× 8 846
Rosalía Lira Mexico 14 1.0k 1.6× 621 1.4× 342 0.9× 187 1.0× 144 1.3× 30 1.4k
Sara C. Smelt United Kingdom 8 386 0.6× 294 0.7× 215 0.6× 128 0.7× 155 1.4× 9 651
E D Franke United States 13 785 1.2× 384 0.9× 233 0.6× 149 0.8× 80 0.7× 18 1.0k
S. Herath United Kingdom 13 315 0.5× 250 0.6× 376 1.0× 80 0.4× 40 0.4× 22 861

Countries citing papers authored by J P Farrell

Since Specialization
Citations

This map shows the geographic impact of J P Farrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J P Farrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J P Farrell more than expected).

Fields of papers citing papers by J P Farrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J P Farrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J P Farrell. The network helps show where J P Farrell may publish in the future.

Co-authorship network of co-authors of J P Farrell

This figure shows the co-authorship network connecting the top 25 collaborators of J P Farrell. A scholar is included among the top collaborators of J P Farrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J P Farrell. J P Farrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Armstrong, Elina, et al.. (2001). Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice. Gene Therapy. 8(5). 354–361. 39 indexed citations
3.
Li, Jian, Shaheen S. Sutterwala, & J P Farrell. (1997). Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production. Infection and Immunity. 65(8). 3225–3230. 30 indexed citations
4.
Nabors, Gary S. & J P Farrell. (1996). Successful Chemotherapy in Experimental Leishmaniasis Is Influenced by the Polarity of the T Cell Response Before Treatment. The Journal of Infectious Diseases. 173(4). 979–986. 25 indexed citations
5.
Nabors, Gary S. & J P Farrell. (1995). Activity of Pentostam (Sodium stibogluconate) against Cutaneous Leishmaniasis in Mice Treated with Neutralizing Anti-Interferon-γ Antibody. American Journal of Tropical Medicine and Hygiene. 53(1). 55–60. 8 indexed citations
6.
Nabors, Gary S. & J P Farrell. (1994). Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infection and Immunity. 62(9). 3655–3662. 38 indexed citations
7.
8.
Müller, Ingrid, Thierry Pedrazzini, J P Farrell, & Jacques Louis. (1989). T-Cell Responses and Immunity to Experimental Infection with Leishmania Major. Annual Review of Immunology. 7(1). 561–578. 112 indexed citations
9.
Farrell, J P, Ingrid Müller, & J A Louis. (1989). A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice.. The Journal of Immunology. 142(6). 2052–2056. 61 indexed citations
10.
Kirkpatrick, Carl E., Thomas J. Nolan, & J P Farrell. (1987). Rate ofLeishmania-induced skin-lesion development in rodents depends on the site of inoculation. Parasitology. 94(3). 451–465. 25 indexed citations
11.
Louis, J A, Thierry Pedrazzini, Richard G. Titus, et al.. (1987). Subsets of specific T cells and experimental cutaneous leishmaniasis. Annales de l Institut Pasteur Immunologie. 138(5). 755–758. 11 indexed citations
12.
Abraham, David, et al.. (1986). Cellular and humoral immune responses of jirds resistant to Dipetalonema viteae infection. Infection and Immunity. 52(3). 742–747. 6 indexed citations
13.
Abraham, David, et al.. (1986). Protective immune responses of the jird to larval Dipetalonema viteae.. PubMed. 57(1). 165–9. 33 indexed citations
14.
Kirkpatrick, Carl E., J P Farrell, John F. Warner, & Gunther Dennert. (1985). Participation of natural killer cells in the recovery of mice from visceral leishmaniasis. Cellular Immunology. 92(1). 163–171. 33 indexed citations
15.
Kirkpatrick, Carl E. & J P Farrell. (1984). Mechanisms of depression of splenic natural killer cell function in C57BL/6 mice infected with Leishmania donovani. Cellular Immunology. 87(2). 601–612. 7 indexed citations
16.
Kirkpatrick, Carl E. & J P Farrell. (1984). Splenic natural killer-cell activity in mice infected with Leishmania donovani. Cellular Immunology. 85(1). 201–214. 23 indexed citations
17.
Kirkpatrick, Carl E. & J P Farrell. (1982). Leishmaniasis in beige mice. Infection and Immunity. 38(3). 1208–1216. 49 indexed citations
18.
Farrell, J P, et al.. (1982). Pathogenesis of anaemia in hamsters infected withLeishmania donovani. Parasitology Research. 68(1). 27–32. 8 indexed citations
19.
Scott, Phillip & J P Farrell. (1981). Experimental cutaneous leishmaniasis. I. Nonspecific immunodepression in BALB/c mice infected with Leishmania tropica.. The Journal of Immunology. 127(6). 2395–2400. 58 indexed citations
20.
Rezai, Hamid R., et al.. (1980). Immunological responses of L. donovani infection in mice and significance of T cell in resistance to experimental leishmaniasis.. PubMed. 40(3). 508–14. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026